TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Shire Gains as it Seeks European Approval For Dry Eye Treatment
STOCKS

Biotech movers: Shire rises on encouraging angioedema results

  • By William McConnell
  • Feb 23, 2017 9:20 AM EST
PRESS RELEASES

Cyclacel Pharmaceuticals To Release Second Quarter 2020 Financial Results

  • By GlobeNewswire
  • Aug 5, 2020 7:00 AM EDT
PRESS RELEASES

Cyclacel Announces Closing Of $20 Million Public Offering

  • By GlobeNewswire
  • Apr 24, 2020 4:05 PM EDT
PRESS RELEASES

CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING

  • By GlobeNewswire
  • Apr 21, 2020 8:27 AM EDT
PRESS RELEASES

Cyclacel Announces Reverse Stock Split

  • By GlobeNewswire
  • Apr 14, 2020 12:30 PM EDT
Shire Gains as it Seeks European Approval For Dry Eye Treatment
STOCKS

Biotech movers: Shire rises on encouraging angioedema results

  • By William McConnell
  • Feb 23, 2017 9:20 AM EST
Moleculin Biotech gets good verbal Ok from FDA which should cut time to Phase 1/2 trial down
STOCKS

Moleculin Biotech gets good verbal OK from FDA which should cut time to phase 1/2 trial down

  • By Bill Meagher
  • Nov 18, 2016 4:31 PM EST
Here Comes the Bear Raid on Starbucks, Maybe
STOCKS

Cyclacel stock runs on momentum rocket fueled by 'Dumb & Dumber' optimism

  • By Adam Feuerstein
  • Aug 22, 2016 12:36 PM EDT
5 Best-Positioned Biotech Stocks on Brexit Volatility
MARKETS

Here's Why Cyclacel Pharmaceuticals (CYCC) Stock Is Surging Today

  • By Kaya Yurieff
  • Aug 22, 2016 12:18 PM EDT
Cerner Stock Jumps, Leerink Raises Price Target
MARKETS

Cyclacel pharmaceuticals (cycc) stock pops, h.c. wainwright bullish

  • By Annie Palmer
  • Aug 12, 2016 1:10 PM EDT
Online Retailer Zulily Looking to Win Over Skeptical Investors
OPINION

5 Stocks Ready for Breakouts

  • By Roberto Pedone
  • Jun 19, 2015 12:14 PM EDT
3 Stocks Under $10 to Trade for Breakouts
INVESTING

3 Stocks Under $10 to Trade for Breakouts

  • By Roberto Pedone
  • Apr 14, 2015 2:11 PM EDT
5 Stocks Under $10 Set to Soar: Venaxis, McDermott and More
INVESTING

5 Stocks Under $10 Set to Soar: Venaxis, McDermott and More

  • By Roberto Pedone
  • Feb 19, 2015 7:00 AM EST
6 Terrifying Companies That Have Slashed Their Dividends Or Might Very Soon
OPINION

Billionaires Got Burned by These Six Struggling Stocks in 2014

  • By Emily Stewart
  • Jan 3, 2015 9:20 AM EST
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta

  • By Adam Feuerstein
  • Oct 25, 2013 6:00 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

5 Stocks Insiders Love Right Now

  • By Roberto Pedone
  • May 29, 2013 12:38 PM EDT
Top Insider Trades: AYR IVH PTGI REED
STOCKS

Top Insider Trades: RH, AMBI, LULU, CYCC

  • By Jonathan Moreland
  • May 23, 2013 9:17 AM EDT
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Stocks Set to Soar on Bullish Earnings

  • By Roberto Pedone
  • Mar 25, 2013 1:59 PM EDT
3 Unusual-Volue Stocks on the Rise
INVESTING

4 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Jan 25, 2013 2:46 PM EST
5 Stocks Insiders Love Right Now
INVESTING

4 Biotech Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Oct 25, 2012 2:45 PM EDT
4 Stocks Under $10 Making Big Moves
INVESTING

5 Stocks Ready to Break Out

  • By Roberto Pedone
  • Oct 19, 2012 12:32 PM EDT
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

  • By Mark Messier
  • Oct 17, 2012 7:00 AM EDT
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Biotech Stock Mailbag: Pending Sarepta Results, Cyclacel

  • By Adam Feuerstein
  • Sep 21, 2012 8:16 AM EDT
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Sep 20, 2012 1:51 PM EDT
Cisco CEO Chambers: We're in China for the Long Run
INVESTING

Biotech Stock Live Chat: Fall Preview

  • By Adam Feuerstein
  • Sep 19, 2012 11:53 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.